OGEN:US
$0.179
5.471%
Oragenics Inc.News & Events
Last updated: May 7, 2025, 12:41 AM ET
Oragenics, Inc. to Participate at the 15th Annual Traumatic Brain Injury Conference
GlobeNewswire APR 23, 2025 8:30 AM EDTSARASOTA, Fla., April 23, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...READ ARTICLEOragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial
GlobeNewswire APR 9, 2025 8:58 AM EDTSARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...READ ARTICLEOragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
GlobeNewswire APR 7, 2025 4:30 PM EDTSARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...READ ARTICLEOragenics, Inc. Provides Q1 2025 Shareholder Update on Strategic and Financial Progress
GlobeNewswire MAR 27, 2025 8:30 AM EDTSARASOTA, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...READ ARTICLEOragenics, Inc. Announces Filing of 2024 Annual Report on Form 10-K
GlobeNewswire MAR 18, 2025 5:33 PM EDTSARASOTA, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...READ ARTICLEOragenics, Inc. Submits Investigator's Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury (mTBI)
GlobeNewswire MAR 6, 2025 9:30 AM ESTSARASOTA, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biote...READ ARTICLEOragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Present at the Emergencies in Medicine Conference on Advancing Concussion Treatment
GlobeNewswire FEB 25, 2025 8:30 AM ESTSARASOTA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotec...READ ARTICLEOragenics, Inc. Chief Medical Officer, Dr. James Kelly, Joins the Medical Board of The Leigh Steinberg Foundation for Concussion, Traumatic Brain Injury, and Brain Health
GlobeNewswire FEB 24, 2025 8:30 AM ESTSARASOTA, Fla., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotec...READ ARTICLEOragenics, Inc. Announces Partnership with BRAINBox Solutions to Revolutionize Concussion Diagnosis and Treatment
GlobeNewswire FEB 11, 2025 8:30 AM ESTSARASOTA, Fla. and RICHMOND, Va., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE America...READ ARTICLEOragenics, Inc. Chief Medical Officer, Dr. James P. Kelly, to Participate in the 12th Annual Brain Health Summit at the Leigh Steinberg Super Bowl Party 2025
GlobeNewswire FEB 5, 2025 8:15 AM ESTSARASOTA, Fla., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotec...READ ARTICLE